These novel compounds were evaluated for inhibition of the low K,, CAMP-selective, cGMP- inhibited phosphodiesterase (PDE 111) derived from cat heart and hemodynamic activity in the ganglion-and@-blocked anesthetized cat. The most potent PDE I11 inhibitor of the series was 6-[4-(5-methyl-3-0~ 0-2, 3, 4, 5-tetrahydropyridazin-6-y1)-phenyl] pyridazin-3 (2H)-one (ICm= 0.07 pM), which also retained the greatest inotrope and vasodilator ( ...